These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23327739)
21. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC; Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292 [TBL] [Abstract][Full Text] [Related]
22. Cross state-dependency of learning between tramadol and MK-801 in the mouse dorsal hippocampus: involvement of nitric oxide (NO) signaling pathway. Jafari-Sabet M; Amiri S; Ataee R Psychopharmacology (Berl); 2018 Jul; 235(7):1987-1999. PubMed ID: 29679289 [TBL] [Abstract][Full Text] [Related]
23. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Schwartz JC Br J Pharmacol; 2011 Jun; 163(4):713-21. PubMed ID: 21615387 [TBL] [Abstract][Full Text] [Related]
24. Effects of MK-801 and nicotine combinations on memory consolidation in CD1 mice. Ciamei A; Aversano M; Cestari V; Castellano C Psychopharmacology (Berl); 2001 Mar; 154(2):126-30. PubMed ID: 11314674 [TBL] [Abstract][Full Text] [Related]
25. Anticonvulsant activity of the histamine H3 receptor inverse agonist pitolisant in an electrical kindling model of epilepsy. Beheshti S; Wesal MW Neurosci Lett; 2022 Jun; 782():136685. PubMed ID: 35598693 [TBL] [Abstract][Full Text] [Related]
26. Systemic administration of polyaminergic agents modulate fear conditioning in rats. Camera K; Mello CF; Ceretta AP; Rubin MA Psychopharmacology (Berl); 2007 Jul; 192(4):457-64. PubMed ID: 17318505 [TBL] [Abstract][Full Text] [Related]
27. Pitolisant and intravenous cocaine self-administration in mice. Huyts B; Brabant C; Tirelli E Eur J Pharmacol; 2019 May; 851():63-68. PubMed ID: 30771351 [TBL] [Abstract][Full Text] [Related]
28. Overdose of the histamine H₃ inverse agonist pitolisant increases thermal pain thresholds. Zhang DD; Sisignano M; Schuh CD; Sander K; Stark H; Scholich K Inflamm Res; 2012 Nov; 61(11):1283-91. PubMed ID: 22820944 [TBL] [Abstract][Full Text] [Related]
29. Action of Pitolisant on the stimulant and rewarding effects of cocaine in mice. Brabant C; Charlier Y; Navacerrada MES; Alleva L; Tirelli E Eur J Pharmacol; 2016 Nov; 791():552-559. PubMed ID: 27568835 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area. Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448 [TBL] [Abstract][Full Text] [Related]
31. NMDA or 5-HT receptor antagonists impair memory reconsolidation and induce various types of amnesia. Nikitin VP; Solntseva SV; Kozyrev SA; Nikitin PV; Shevelkin AV Behav Brain Res; 2018 Jun; 345():72-82. PubMed ID: 29499285 [TBL] [Abstract][Full Text] [Related]
32. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats. Sadek B; Saad A; Subramanian D; Shafiullah M; Łażewska D; Kieć-Kononowiczc K Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191 [TBL] [Abstract][Full Text] [Related]
33. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Parada-Turska J; Turski WA Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871 [TBL] [Abstract][Full Text] [Related]
34. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Csernansky JG; Martin M; Shah R; Bertchume A; Colvin J; Dong H Neuropsychopharmacology; 2005 Dec; 30(12):2135-43. PubMed ID: 15956997 [TBL] [Abstract][Full Text] [Related]
35. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Bast T; Zhang WN; Feldon J Hippocampus; 2003; 13(6):657-75. PubMed ID: 12962312 [TBL] [Abstract][Full Text] [Related]
36. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review. Leu-Semenescu S; Nittur N; Golmard JL; Arnulf I Sleep Med; 2014 Jun; 15(6):681-7. PubMed ID: 24854887 [TBL] [Abstract][Full Text] [Related]
37. The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat. Baldi E; Bucherelli C; Schunack W; Cenni G; Blandina P; Passani MB Neuropharmacology; 2005 Feb; 48(2):246-51. PubMed ID: 15695163 [TBL] [Abstract][Full Text] [Related]
38. Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model. Kotańska M; Mika K; Sałaciak K; Wheeler L; Sapa J; Kieć-Kononowicz K; Pytka K Pharmacol Biochem Behav; 2020 Sep; 196():172974. PubMed ID: 32565240 [TBL] [Abstract][Full Text] [Related]
39. Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Cangioli I; Baldi E; Mannaioni PF; Bucherelli C; Blandina P; Passani MB Eur J Neurosci; 2002 Aug; 16(3):521-8. PubMed ID: 12193196 [TBL] [Abstract][Full Text] [Related]
40. The histamine H Kotańska M; Kuder KJ; Szczepańska K; Sapa J; Kieć-Kononowicz K Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):875-881. PubMed ID: 29802412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]